The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The federal government has initiated a lawsuit against leading Pharmacy Benefit Managers (PBMs) — Caremark, Express Scripts, and OptumRx — accusing them of anticompetitive practices that have driven ...
“We are able to purchase drugs on a federal pricing program called 340 B. Starting in July, we noticed a dramatic increase in our insulin costs." A disproportionate share hospital treats a ...
People with type 1 or type 2 diabetes could soon benefit from weekly insulin injections after new research showed they are as effective at controlling blood sugar levels as daily jabs of long-acting ...